Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-094672
Filing Date
2011-11-03
Accepted
2011-11-03 11:14:27
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b87794ae10vq.htm 10-Q 513062
2 EX-31.1 b87794aexv31w1.htm EX-31.1 7559
3 EX-31.2 b87794aexv31w2.htm EX-31.2 7598
4 EX-32.1 b87794aexv32w1.htm EX-32.1 3153
  Complete submission text file 0000950123-11-094672.txt   2551581

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT alks-20110930.xml EX-101.INS 355864
6 EX-101 SCHEMA DOCUMENT alks-20110930.xsd EX-101.SCH 14561
7 EX-101 CALCULATION LINKBASE DOCUMENT alks-20110930_cal.xml EX-101.CAL 40980
8 EX-101 LABELS LINKBASE DOCUMENT alks-20110930_lab.xml EX-101.LAB 151690
9 EX-101 PRESENTATION LINKBASE DOCUMENT alks-20110930_pre.xml EX-101.PRE 107039
10 EX-101 DEFINITION LINKBASE DOCUMENT alks-20110930_def.xml EX-101.DEF 49081
Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000 00-353-1-649-2000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 111176547
SIC: 2834 Pharmaceutical Preparations